Does Deficiency in Vitamin D Induced Hypercoagulation or Thrombin Generation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01761669|
Recruitment Status : Completed
First Posted : January 7, 2013
Last Update Posted : November 3, 2016
Working hypothesis and aims: The aim of our study is to investigate whether vitamin D deficiency could cause increased thrombin generation and a hypercoagulable state healthy volunteers.
In total 400 healthy volunteers are planned for inclusion in this trial. After signing an informed consent two blood samples will be obtained from each participant.
Expected results: invastigator expect to find that volunteers with vitamin D deficiency will have thrombin generation curve compatible with hypercoagulable state and returning to normal after treatment with vitamin D
|Condition or disease||Intervention/treatment|
|Cardiovascular Disease||Drug: Vitamin D|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||400 participants|
|Target Follow-Up Duration:||3 Months|
|Study Start Date :||April 2013|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||July 2013|
Drug: Vitamin D
- the correlation between vitamin D levels and endogenous thrombin potential [ Time Frame: 3 month ]one blood test
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01761669
|Afula, Israel, 19101|
|Principal Investigator:||mazen elias, MD||Emek Medical Center|